|
|
Volumn 17, Issue 2, 2008, Pages 91-92
|
|
Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox
|
|
Author keywords
Atherosclerosis; Lupus; Outcome; Prognosis
|
|
Indexed keywords
ANTIMALARIAL AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CORTICOSTEROID;
HYDROXYCHLOROQUINE;
METHOTREXATE;
SALCATONIN;
VITAMIN D;
BEHAVIOR THERAPY;
BODY MASS;
COMORBIDITY;
EXERCISE;
FOLLOW UP;
HEALTH CARE;
HEALTH CARE ACCESS;
HEALTH CARE PERSONNEL;
HUMAN;
MORBIDITY;
MORTALITY;
OSTEOPOROSIS;
OUTCOME ASSESSMENT;
PHYSICIAN;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RHEUMATOLOGY;
SHORT SURVEY;
SMOKING CESSATION;
SOCIOECONOMICS;
STRESS ECHOCARDIOGRAPHY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
HUMANS;
INTERDISCIPLINARY COMMUNICATION;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
PHYSICIAN'S ROLE;
PHYSICIAN-PATIENT RELATIONS;
PRIMARY HEALTH CARE;
PROGNOSIS;
QUALITY OF LIFE;
RHEUMATOLOGY;
TREATMENT OUTCOME;
|
|
EID: 40449114387
PISSN: 09612033
EISSN: None
Source Type: Journal
DOI: 10.1177/0961203307086267 Document Type: Short Survey |
|
Times cited : (16)
|
|
References (0)
|
